Myocardial injury after aortoiliac revascularization for extensive disease: A survival analysis
Tam metin
Benzer Belgeler
In their study, the authors reported that additional tirofiban usage significantly improves myocardial reper- fusion, ST-segment resolution, in-hospital mortality rate, and
Large-scale randomized clinical trials such as the Heart Outcomes Prevention Evaluation (HOPE) (4) and the European Trial on Reduction of Cardiac Events with Perindopril in
Myocardial infarction (MI) is very rare during pregnancy (1/10000), happens mostly during the third trimester and puerperium and mortality rates are high (19-21 %) (1).. In most
Brain natriuretic peptide levels were higher (p=0.003 for basal BNP and p<0.001 for one month BNP) in patients developing symptomatic heart failure during follow-up irrespective
Reperfusion strategies in patients with STEMI are fibrinolytic therapy, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) surgery..
In-hospital mortality with percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) in the early revas- cularization arm of the randomized SHOCK
In this section, we shall elucidate the interaction of form with function and offer surgical approaches in the treatment of heart failure in patients with dilated left
It has been suggested that COHb causes myocardial infarction by severe generalized tissue hypoxia and a direct toxic effect on the myocardial mitochondria, in patients both